Akèy › Maladi otoim › Kalifòni › Los Angeles
Etid klinik pou Maladi otoim nan Los Angeles, CA
12 etid pou Maladi otoim ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
Ap rekriteFaz 3
- University of Southern California, Los Angeles
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Ap rekriteFaz 3
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Ap rekriteFaz 3
- University of California, Los Angeles-UCLA, Los Angeles
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Ap rekriteFaz 3
- Site Number - 1023, Los Angeles
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Ap rekriteFaz 2/3
- Ronald Reagan UCLA Medical Center, Los Angeles
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- UCLA, Los Angeles
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Ap rekriteFaz 1
- Children's Hospital Los Angeles Division Of Rheumatology, Los Angeles
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Ap rekriteFaz 1
- UCLA Medical Center, Los Angeles
Central Vein Sign in Multiple Sclerosis Extension Study
Ap rekrite
- Cedars-Sinai Medical Center, Los Angeles
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- MiraKind, Los Angeles
Etid Maladi otoim nan lòt vil
- Houston, TX21 etid
- Washington, DC19 etid
- New York City, NY19 etid
- Philadelphia, PA16 etid
- Durham, NC15 etid
- Boston, MA13 etid
- Chicago, IL12 etid
- Dallas, TX9 etid
- Atlanta, GA8 etid
- Portland, OR8 etid
- Milwaukee, WI8 etid
- Cleveland, OH8 etid
Lòt etid nan Los Angeles
- Kansè Poumon ki pa ti selil87 etid
- Kansè (tout kalite)74 etid
- Kansè nan tete73 etid
- Kansè pwostat61 etid
- Kansè kolorektal59 etid
- Kansè Metastatik57 etid
- Kansè ovè50 etid
- Kansè poumon45 etid
- Karsinòm selil skuamèz tèt ak kou42 etid
- Kansè pankreyas35 etid
- Kansè Endomèt34 etid
- Melanom34 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.